Sep 18, 2023 by James HalleyWhy Shares of Iovance Biotherapeutics Jumped MondayThe company's stock rally began on Friday.
Sep 15, 2023 by James HalleyWhy Shares of Dyne Therapeutics Fell This WeekInsiders sold more than 15,000 shares of company stock on Tuesday.
Sep 15, 2023 by James HalleyWhy Shares of ImmunityBio Jumped This WeekThe company's founder is spending his own money to help finance the business's efforts.
Sep 15, 2023 by James Halley3 AI Drug Discovery Stocks to WatchThe high cost of developing drugs makes the use of artificial intelligence a natural fit for pharmaceutical companies.
Sep 15, 2023 by James Halley3 Top Healthcare Stocks Defying the Bear MarketRevenue at all three companies improved last quarter, and their share prices have followed suit.
Sep 14, 2023 by James HalleyWhy Shares of Tango Therapeutics Climbed This WeekThe company got the go-ahead last week from the FDA for a drug's IND.
Sep 14, 2023 by James HalleyWhy Shares of Iovance Biotherapeutics Dropped ThursdayThe biotech stock's lead therapy is looking at some competition.
Sep 13, 2023 by James HalleyWhy Shares of Rocket Pharmaceuticals Are Taking Off on WednesdayThe late-stage pharmaceutical company said it had reached an agreement with the Food and Drug Administration regarding a phase 2 trial for a Danon disease therapy.
Sep 12, 2023 by James HalleyWhy Shares of Orthofix Medical Are Plummeting on TuesdayThe company had a big leadership change after an investigation.
Sep 12, 2023 by James HalleyWhy Shares of The Beauty Health Company Are Soaring TuesdayThe company announced a big reorganization.
Sep 12, 2023 by James HalleyWhy Shares of MoonLake Immunotherapeutics Are Rising TuesdayA competitor's clinical trial stumble may be benefiting MoonLake.
Sep 11, 2023 by James HalleyWhy Shares of EyePoint Pharmaceuticals Were Rising MondayThe company reported positive trial data for its lead therapy to treat two different eye conditions.
Sep 11, 2023 by James HalleyWhy Shares of Bicycle Therapeutics Were Rising on MondayThe company said it is working with the FDA to structure a phase 2/3 trial for its bladder cancer therapy.
Sep 11, 2023 by James HalleyWhy Shares of Crinetics Pharmaceuticals Are Jumping MondayThe biotech company reported positive phase 3 trial results.
Sep 9, 2023 by James Halley3 Pharmaceutical Stocks That Are Too Cheap to IgnoreViatris, GSK, and Organon are all trading at less than 7 times earnings.
Sep 8, 2023 by James HalleyWhy Shares of Agiliti Dropped This WeekThe medical equipment management and service solutions company has received multiple analyst downgrades.
Sep 8, 2023 by James HalleyWhy Shares of Insmed Are Soaring This WeekThe biotech company announced positive top-line trial results and received upgrades from analysts.
Sep 7, 2023 by James HalleyWhy Shares of Phibro Animal Health Are Dropping This WeekThe company's shares have been slipping since it announced fiscal 2023 fourth-quarter earnings.
Sep 7, 2023 by James HalleyWhy Shares of Neogen Are Slumping This WeekThe company said it is seeing lower first-quarter numbers than previously expected.
Sep 7, 2023 by James HalleyWhy Shares of Arcutis Biotherapeutics Fell This WeekThe company released phase 3 trial results for an atopic dermatitis cream.
